TP53 and neoplasm: As expected, cell lines with wild-type TP53 responded to Nutlin-3a exposure by activation of p53 and its downstream targets, including p21 and MDM2, whereas tumours with mutated TP53, irrespective of mutation site, did not respond to Nutlin-3a alone.